Search

Objectives Chronic Disease Self-Management Program (CDSMP) has been demonstrated effective in addressing the self-management of chronic conditions among older adults. With a higher attrition rate, this study investigated whether attending with family members influenced completion of and benefits accrued from the CDSMP. Methods The baseline data were collected from CDSMP participants in New York State (n = 4184), and the follow-up data were collected from completers (attended 4+ sessions) (n = 293). Multi-level logistic regression was employed to predict the association between family accompany and program completion. Paired sample t-test was used to compare the differences in benefits from CDSMP after six months. Results Attending with family members was associated with a higher likelihood of completing the CDSMP (OR = 1.626, p Discussion Engaging family members may increase CDSMP participants’ motivation to complete the program. CDSMP providers should encourage participants to attend with their family members.

Background: Patients with diabetes and disabilities often have more difficulties in managing their diabetes. Little is known about how disabilities affect their use of diabetes education program. P...

Aims: Research has reported a lack of practice of early intervention for substance use disorders among primary healthcare professionals, and only a fraction of patients were asked about their substance use when visiting a primary healthcare office. This study examines conditions that may influence the adoption of early intervention [i.e., screening, brief intervention and referral to treatment (SBIRT)] among primary healthcare professionals. Methods: A pilot survey was emailed to primary care physicians, nurse practitioners, and physician assistants in New York State, and 248 recipients responded to the survey. Findings: Three areas appear to be associated with the adoption of SBIRT: percentage of respondents’ patients using marijuana (β = 0.14; p

The Chronic Disease Self-Management Program (CDSMP) was developed to advance participants' self-care of chronic illness and may be offered to both individuals with chronic conditions and their caregivers. Previous studies of CDSMP have identified multiple resulting health benefits for participants as well as factors associated with participants' completion rates. This study investigated differences on these issues between caregiving and non-caregiving participants.Secondary analysis using regression analysis to predict the outcome.Baseline data were collected directly from adult (over 18 years) participants of CDSMP workshops in New York State from 2012 to 2015 (n = 2685). Multi-level logistic regression analysis was used to compare the difference on completion of workshops (attended four or more of sessions) and contributing factors with the independent variable of whether participants provided care/assistance to a family member or friends with long-term illness or disability. Additional individual-level variables controlled for in the model were age, gender, race/ethnicity, living arrangement, education, the number of chronic conditions and disabilities; as were workshop-level characteristics of class size, language used, workshop leader experience, location urbanity and delivery site type.Participants who provided care to family or friends were 28% more likely to complete the workshop compared with those who did not (odds ratio = 1.279, P 0.05). Different factors influenced the completion of CDSMP workshop for caregivers and non-caregivers.People who provide care to others appeared to have stronger motivation to complete the workshops with greater benefits. Agencies offering CDSMP should encourage caregivers to attend.

Objective: To study the wound degree and ovarian function of ultrasound interventional and laparoscopic surgeries for ovarian cyst pediculotorsion. Methods: Patients with ovarian cyst pediculotorsion admitted to Affiliated Hospital of Hebei University from May 2012 to August 2015 were selected. Patients underwent emergency ultrasound interventional operation were allocated into ultrasound intervention group and patients underwent laparoscopic surgery were allocated into laparoscopic group. The patients' conditions of two groups in perioperative period were compared. Before and after operation, the serum contents of total bilirubin, albumin, creatinine, blood urea nitrogen, tumor necrosis factor-alpha (TNF-a), interleukin-1b (IL-1b) and IL-6 were measured respectively. Serum contents of follicle-stimulating hormone, luteinizing hormone and estradiol were measured at 3 months, 6 months and 12 months after operation. Results: The operation time of ultrasound intervention group was shorter (P < 0.05) and the medical fees of it was lower than laparoscopic group (P < 0.05), while the serum contents of total bilirubin, albumin, creatinine and blood urea nitrogen during the perioperative period of two groups had no obvious changes and differences (P > 0.05). There was no significant difference in the recurrence rate after operation (P > 0.05). There was no significant difference in the serum contents of TNF-a, IL-1b, and IL-6 before and after operation in ultrasound intervention group (P > 0.05). While in laparoscopic group, serum contents of TNF-a, IL-1b and IL-6 after operation were significantly higher than those before operation (P < 0.05). And the serum contents of TNF-a, IL-1b and IL-6 after operation in ultrasound intervention group were significantly lower than those in laparoscopic group before operation (P < 0.05). The serum contents of follicle-stimulating hormone, luteinizing hormone and estradiol between two groups were not significantly different at 3 months, 6 months and 12 months after operation (P > 0.05). Conclusions: Ultrasound interventional surgery has quite the same curative effect as laparoscopic surgery in ovarian cyst pedicle pediculotorsion, which also can reduce the surgical trauma, shorten the operation time and lower the operation cost.

Study aims were to explore differences in predictors of respite care use between older (aged 65+) and younger caregivers (aged 18-64 years), and associations between caregiving load and respite care use using multivariate logistic regression analysis and unpaid caregiver (n= 10,500) data from the 2009 California Health Interview Survey. Caregiving load comprised number of care recipients, weekly hours in caregiving, and caregiving duration. Variables with a significant association with respite care for older caregivers were female gender, income, and health insurance. For younger caregivers, respite care use associations were with ethnicity, caregiving relationship, education, and availability of substitute help.

BACKGROUND The aim of this study was to investigate the feasibility and clinical value of transvaginal surgical treatment for cesarean scar pregnancy (CSP-II). MATERIAL AND METHODS This study was a retrospective analysis of 25 CSP-II patients who received transvaginal surgical treatments. These patients were admitted in our hospital between January 2010 and June 2012. RESULTS All surgical treatments were successful without overt complications. The average operation time was 61.5 minutes, the average intraoperative blood loss was 60.5 ml, the average hospital stay was 9.4 days and the average time that blood β-human chorionic gonadotropin (β-HCG) returned to normal range was 15 days. In all 25 patients, the cesarean scar mass located at the anterior wall of the lower uterine segment disappeared by B-ultrasound examination within 1 or 2 weeks after surgery. Postoperatively, the normal menstrual period started again with an average time of 28.9 days. No menstruation-related abnormalities, such as menstrual dripping or an abnormal amount of blood, were reported after surgery. CONCLUSIONS Transvaginal surgery for CSP-II is a novel surgical approach. It has several advantages, including a thorough one-time treatment lesion clearance, short operation time, minimized trauma, minimal intraoperative blood loss, quick reduction of blood β-HCG, and rapid menstruation recovery. It is a simple and feasible surgical approach of great clinical value and few treatment-related complications.

Although previous studies have established a strong association between diabetes and disability, little is known regarding the impact of disability on access to diabetes care among older adults with diabetes. The purpose of this study is to examine the impact of disability on accessing diabetes care among older adults who are living with diabetes. This study used survey data from the 2014 Behavioral Risk Factor Surveillance System (BRFSS). The sample included adults age 50 and over who have diabetes. Multivariate logistic regression analysis was conducted to examine the impact of disability on accessing diabetes care among older adults with diabetes. Two dependent variables were identified to measure diabetes care access: (1) receipt of a course or class on managing diabetes and (2) visit to a health professional in the past year for diabetes. 47.30% of the sample reported not having received diabetes education and 10.86% did not visit health professionals for diabetes in the past year. Older adults with diabetes who had disabilities were more likely to have received diabetes management education (OR=1.17, p

A new technique has successfully established the non-obese diabetic/severely combined immunodeficiency (NOD/SCID) mouse model of ovarian cancer. Under 4% chloral hydrate (0.1 mL/g dose) anesthesia, female mice were inoculated with tumor-cell suspension. The expression rate of OVCAR3 to CA125 was assessed using flow cytometry. The inoculated site was hand palpated and the signs and symptoms related to tumor growth were observed with the naked eye. The allophycocyanin (APC) indirectly labeled mouse-antihuman CA125 and fluorescein isothiocyanate (FITC)-labeled anti-mouse MHC Class I molecule (H-2K(d)/H-2D(d)) were observed using a confocal laser scanning microscope. The animal model of ovarian cancer constructed using this method can more directly reflect the characteristics of cancer cells. It provides reliable experimental results and presents a technical platform for the research of ovarian cancer stem cells.